您要查找的是不是：
- Enzymatic Vitreolysis with Recombinant Microplasminogen and Tissue Plasminogen Activator. Chen W（陈武）; Huang X; Ma XW; et al.
- Hacke W, Kaste M, Fieschi C. Intrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA, 1995, 247 (13):1017. 郑家生;崔雄伟;赵永春;等.;急性缺血性脑卒中超选择动脉溶栓疗法的并发症分析
- Objective To investigate the anticoagulative and fibrinolytic effects of lumbrokinase and their relation to tissue plasminogen activator (t-PA). 目的探讨蚓激酶抗凝、纤溶机制及其与组织型纤溶酶原激活剂(t-PA)的关系。
- Tissue plasminogen activator, for example, can be given within 3 hours of a stroke, and similar treatments are being developed for ICH. 例如，可在中风发生后的3小时内对病人给予组织纤溶酶原激活物进行治疗，对脑出血病人，类似的治疗手段也在开展当中。
- A stroke drug known as tPA, or tissue plasminogen activator, has been a lightning rod since it was first approved in the United States in 1996. 自从1996年在美国被发现以来，已经成为中风的“避雷针”。
- Intraenous administration of recombinant tissue plasminogen actiator remains the most beneficial proen interention for emergency treatment of stroke. 在卒中的介入急救中，静脉注射重组组织纤溶酶原激活剂依然被认定为最有效的.
- Tissue plasminogen actiator, for example, can be gien within 3 hours of a stroke, and similar treatments are being deeloped for ICH. 例如，可在中风发生后的3小时内对病人给予组织纤溶酶原激活物进行治疗，对脑出血病人，类似的治疗手段也在开展当中。
- With that information,they determined it was safe to go ahead and give him tPA (tissue plasminogen activator),the same clotbusting drug used to stop heart attacks. 掌握了这些情况，医生们断定可以安全地继续进行治疗。他们给库比兹使用tPA(组织血浆酶原激活剂)。这种冲破血栓的药剂也用于治疗心脏病。
- The effect of Pentainidine lsethionate(PI)on tissue plasminogen activator(tPA),plasmin(Pli)and plasminogen(Plg)in vitro were compared with tranexamic acid(AMCA). 对羟乙酸戊烷脒（PI）对组织型纤溶酶元激活因子（t－PA），纤溶酶元（Plg）及纤溶酶（Pli）的作用进行体外测定，并与止血环酸（AMCA）的作用进行比较。
- With that information, they determined it was safe to go ahead and give him tPA (tissue plasminogen activator), the same clotbusting drug used to stop heart attacks. 掌握了这些情况，医生们断定可以安全地继续进行治疗。他们给库比兹使用tpa(组织血浆酶原激活剂)。这种冲破血栓的药剂也用于治疗心脏病。
- The screening of human tissue plasminogen activator recombinant plasmid showed that the two methods can recognize the positive colones quickly and correctly. 测序结果表明这两种方法能快速，准确地筛选出阳性克隆。
- Levels of tissue plasminogen activator, stromelysin [34], and metalloproteases [38,39] have been shown to decrease in trabecular meshwork cultures treated with dexamethasone. 在地塞米松处理过的小梁细胞中组织纤维蛋白溶酶原激活剂、基质降解酶[34]和金属蛋白酶[38,39]水平下降。
- ObjectiveTo investigate the activity of tissue plasminogen activator(t-PA) and plasminogen activator inhibitor(PAI) in patients with hypertensive disorder complicating pregnancy. 目的探讨妊娠期高血压疾病患者血浆组织型纤溶酶原激活物(t-PA)及其抑制物(PAI)的活性变化。
- Lysis of the hematoma with various enzymes, such as urokinase or tissue plasminogen activator (TPA), and drainage of liquefied clot has become an alternative. 因而，应用不同的酶如尿激酶或组织纤维蛋白溶酶原激活剂来溶解血肿和引流液化的血凝块，成为可供选择的治疗方法。
- Vare and Ptacek document a number of prominent recent examples: Janet L.Rideout (AZT), M.Katharine Holloway and Chen Zhao (protease inhibitors), and Diane Pennica (tissue plasminogen activator). 费尔与泰西格举了近来数个突出的例子为证：赖道特（AZT）、霍洛韦与赵晨（蛋白酶抑制剂）、潘尼卡（组织纤维蛋白溶酶原活化剂）等。
- Objective To observe the effects of high glucose on the production of tissue plasminogen activator (t PA) by human glomerular mesangial cells (MC), its binding ability to the cells, and the role of fibronectin (FN) in this event. 目的 观察高糖状态下系膜细胞与组织型纤溶酶原激活物 (Tissueplasminogen ,t PA)结合力及系膜细胞产生t PA活性改变与纤维连接蛋白 (Fibronectin ,FN)产生的影响。
- Methods:50 cases of acute cerebral infarction were treated with injecting tissue plasminogen activator(tPA) PIEAT(group A) and compared with 180 cases injected urokinase (UK) PIEAT(group B) and 190 cases with UK per intravenous drip(group C). 方法：用颈内动脉插管注射组织型纤溶酶原激活因子（tPA）溶栓治疗急性脑梗塞50例（A组），与同期颈内动脉插管注射尿激酶（UK）溶栓180例（B组）和外周静脉静滴UK190例（C组）进行对比，观察患者失语、昏迷、出血、死亡情况及肌力恢复情况。
- To observe the effect of puerarin on superoxide dismutase (SOD), lipid peroxidation (LPO), tissue plasminogen (TPA) and plasminogen activator inhibitor (PAI 1) of coronary heart disease (CHD) patients. 目的:观察葛根素对冠心病患者血清超氧化物歧化酶(SOD)、过氧化脂质(LPO)、组织型纤维蛋白溶酶原激活物(TPA)及组织型纤维蛋白溶酶原激活物抑制剂(PAI1)的影响。
- To see if iron leels affect stroke outcome, the researchers studied 134 consecutie patients with acute ischemic stroke treated with tissue plasminogen actiator (t-PA) at four centers. 为了搞清楚铁的水平是否会影响中风的转归，研究者们对4个中心的连续134例发生急性缺血性卒中，并用组织纤维蛋白溶酶原激活剂(t-PA)治疗的患者进行了研究。
- tissue plasminogen activator(tPA) 组织纤溶酶原激活剂
